Here’s why Clover Health stock price spiked after earnings

May 09, 2024 01:54 AM AEST | By Invezz
 Here’s why Clover Health stock price spiked after earnings
Image source: Invezz

Clover Health (NASDAQ: CLOV) stock price went parabolic on Wednesday as investors cheered the company’s financial results, forward guidance, and share repurchase program. It surged by over 18%, its best daily performance since August last year.

Clover Health, a former meme stock, published strong results as it moved towards profitability. Its total revenue rose to over $346 million in the quarter, higher than the $321 million it made in the same period in 2023.

Most importantly, the company had its first adjusted EBITDA profit ever as it rose to $6.8 million. Also, it continued to narrow its net loss, which came in at $19 million, an improvement from the $72 million it made in Q1’23.

The company hopes that its business will continue doing well this year. It boosted its revenue guidance to between $1.30 billion and $1.35 billion. Before that, its guidance was between $1.25 billion and $1.30 billion. Its adjusted EBITDA will be between $10 million and $30 million. 

Still, there is one key concern to be aware of as the company authorised a $20 million share repurchase program. Stock buybacks are always welcome since they reduce the number of outstanding shares and boost earnings per share.

Like with dividends, most companies repurchase their shares using their free cash flow. While Clover is expected to narrow its net loss this year, it is not expected to be cash flow positive. As such, I believe that the firm should have waited to constantly become profitable before repurchasing its stock.

I warned the same about Mullen Automotive, an embattled electric vehicle company that implemented a $25 million share repurchase program last year. Its stock has crashed by over 50% this year alone.

For starters, Clover Health is a company that helps people shop for Medicare Advantage plans at a lower cost. It also owns Clover Assistant, which helps physicians to detect, identify, and manage chronic diseases earlier.  It also has a non-insurance business in the Accountable Care Organisation Realising Equity, Access, and Community Health (ACO REACH) model that was started in 2023.

Clover Health became popular in 2021 as it became one of the top meme stocks. At the time, its stock surged to $28.8, giving it a market cap of over $7 billion. Today, its valuation has slumped to just $366 million.

The post Here’s why Clover Health stock price spiked after earnings appeared first on Invezz


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.

AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.